Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 12, 2022

SELL
$0.97 - $3.08 $14,408 - $45,750
-14,854 Closed
0 $0
Q1 2022

May 13, 2022

SELL
$2.55 - $5.23 $2,664 - $5,465
-1,045 Reduced 6.57%
14,854 $43,000
Q4 2021

Feb 11, 2022

SELL
$4.43 - $8.33 $2,108 - $3,965
-476 Reduced 2.91%
15,899 $70,000
Q3 2021

Nov 12, 2021

SELL
$6.07 - $9.89 $2,361 - $3,847
-389 Reduced 2.32%
16,375 $119,000
Q2 2021

Aug 13, 2021

BUY
$9.76 - $14.15 $45,862 - $66,490
4,699 Added 38.95%
16,764 $164,000
Q1 2021

May 07, 2021

BUY
$7.66 - $13.38 $237 - $414
31 Added 0.26%
12,065 $143,000
Q4 2020

Feb 12, 2021

SELL
$6.1 - $7.94 $2,104 - $2,739
-345 Reduced 2.79%
12,034 $94,000
Q3 2020

Nov 04, 2020

BUY
$6.52 - $8.94 $13,163 - $18,049
2,019 Added 19.49%
12,379 $84,000
Q2 2020

Aug 12, 2020

SELL
$6.18 - $10.76 $6,260 - $10,899
-1,013 Reduced 8.91%
10,360 $78,000
Q1 2020

May 04, 2020

SELL
$6.03 - $15.24 $3,961 - $10,012
-657 Reduced 5.46%
11,373 $71,000
Q4 2019

Feb 05, 2020

SELL
$9.07 - $15.84 $916 - $1,599
-101 Reduced 0.83%
12,030 $182,000
Q3 2019

Nov 08, 2019

SELL
$9.63 - $14.0 $2,417 - $3,514
-251 Reduced 2.03%
12,131 $124,000
Q2 2019

Aug 13, 2019

BUY
$13.4 - $17.67 $42,786 - $56,420
3,193 Added 34.75%
12,382 $183,000
Q1 2019

May 06, 2019

BUY
$5.7 - $19.7 $37,859 - $130,847
6,642 Added 260.78%
9,189 $151,000
Q4 2018

Feb 13, 2019

SELL
$5.57 - $11.65 $735 - $1,537
-132 Reduced 4.93%
2,547 $15,000
Q3 2018

Nov 09, 2018

BUY
$11.32 - $15.7 $30,326 - $42,060
2,679 New
2,679 $32,000

Others Institutions Holding MGTA

About Magenta Therapeutics, Inc.


  • Ticker MGTA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 58,890,500
  • Description
  • Magenta Therapeutics, Inc., a clinical-stage biotechnology company, develops medicines to bring the curative power of stem cell transplants to patients with blood cancers, genetic diseases, and autoimmune diseases. It develops MGTA-117, an anti-CD117 antibody that targets hematopoietic stem cells (HSCs) and genetically mutated stem cells that ca...
More about MGTA
Track This Portfolio

Track American International Group, Inc. Portfolio

Follow American International Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on American International Group, Inc. with notifications on news.